Does Tigecycline Cause Liver Enzyme Elevation?
Yes, tigecycline, an intravenous glycylcycline antibiotic used for complicated skin infections, intra-abdominal infections, and community-acquired pneumonia, commonly causes elevations in liver enzymes such as ALT and AST.[1][2]
Clinical trials showed liver enzyme elevations in up to 26% of patients, typically mild to moderate and reversible upon discontinuation. These occurred more frequently than with comparators like vancomycin or imipenem.[3]
How Common Is This Side Effect?
In phase 3 trials:
- ALT elevations (>3x upper limit of normal): 15-26% of tigecycline patients vs. 8-15% in control groups.
- AST elevations: Similar pattern, around 20%.
Post-marketing data from the FDA Adverse Event Reporting System confirms transaminitis as one of the most reported hepatic effects, often within days of starting treatment.[1][4]
What Does This Mean for Patients?
Most cases are asymptomatic and resolve without intervention, but monitoring is recommended, especially in patients with preexisting liver disease or risk factors like obesity or diabetes. Tigecycline's black box warning covers mortality risk but not liver enzymes specifically; however, package inserts advise liver function tests before, during, and after therapy.[2][5]
Why Does Tigecycline Affect the Liver?
Its mechanism involves biliary excretion (59% of dose), which may stress hepatocytes. Unlike tetracyclines, tigecycline inhibits mitochondrial protein synthesis, potentially disrupting liver cell metabolism and leading to enzyme leakage.[3][6]
Compared to Other Antibiotics?
Tigecycline has higher rates of transaminitis than beta-lactams (e.g., piperacillin-tazobactam: <10%) or vancomycin (<5%), but similar to some tetracyclines. It's less hepatotoxic than drugs like azithromycin or nitrofurantoin.[1][7]
When Should You Worry?
Severe elevations (>10x ULN) are rare (<2%), but can signal acute liver injury, especially with prolonged use (>14 days). Risk increases with concurrent hepatotoxins like acetaminophen. Discontinue if jaundice or symptoms appear.[2][4]
[1]: FDA Label for Tygacil (tigecycline)
[2]: Drugs.com - Tigecycline Side Effects
[3]: New England Journal of Medicine - Tigecycline Trials
[4]: PubMed - Tigecycline Hepatotoxicity Review
[5]: LiverTox - Tigecycline
[6]: Clinical Infectious Diseases - Tigecycline Pharmacology
[7]: Antimicrobial Agents and Chemotherapy - Comparative Hepatotoxicity